Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. - Wikidata - wikimedia - TriplyDB

Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

http://www.wikidata.org/entity/Q33234966

about

Retinal Macroglial Responses in Health and Disease From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma Oral microbiome link to neurodegeneration in glaucoma Oxidative stress and the regulation of complement activation in human glaucoma Network analysis of human glaucomatous optic nerve head astrocytes.Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer.The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.Rodent models of glaucoma.Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.Differential gene expression in glaucoma Differential gene expression in mouse retina related to regional differences in vulnerability to hyperoxia Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that models myopia and other risk factors for glaucoma Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice.Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma.Complement in animal development: unexpected roles of a highly conserved pathway.The immune response in glaucoma: a perspective on the roles of oxidative stress Rod photoreceptor ribbon synapses in DBA/2J mice show progressive age-related structural changes.A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor.Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma.Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients.Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice.Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.Immune regulation toward immunomodulation for neuroprotection in glaucoma.Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma Friend or foe? Resolving the impact of glial responses in glaucoma The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway.Exercise reverses age-related vulnerability of the retina to injury by preventing complement-mediated synapse elimination via a BDNF-dependent pathway.Complement expression in the retina is not influenced by short-term pressure elevation.Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma.The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.Complex genetic mechanisms in glaucoma: an overview Challenges in the development of glaucoma neuroprotection therapy.The role of Müller glia and microglia in glaucoma.

P2860

Q26746666-6A568E8C-E12B-47C5-8567-798A0B81A4A3 Q26864408-2B1FB5D5-9B6C-49AD-B511-D44CF2E5E6A7 Q27316016-480BC54F-176A-421D-A125-DA7321A73F14 Q28577665-E150369E-6A4B-4418-B973-98938F380F5A Q33442021-2B384B2E-9D5D-4F71-A1BE-91B177837A42 Q33523671-50BDF7BF-1A04-4A80-94ED-DDF81AD8B57F Q33685823-9DB224DE-C8A4-4907-986F-543BF08C9562 Q33698065-BA35CB20-579D-43BA-BE13-D6C3CF8585AA Q33719355-A74B3A95-EE0E-4F72-98BC-997705BEFD34 Q33790678-EF39B99F-E3C9-42DC-9558-BB35D5998F86 Q33821122-11201302-34D7-47AA-964F-ADB8A592DCCD Q33838251-F277ACD1-7EC1-4D46-A32B-D90485A17A0B Q33845093-3C33EF74-5A4C-4338-97C2-3592BA374608 Q33984464-4D6F54D2-E414-45D2-96C4-3A1AD9EB7520 Q34344142-A8444961-5A7D-45D3-A774-3BF673AC04E1 Q34388254-1128C8E4-0734-4399-B9B1-D439BAACACAE Q34408258-9250CE4D-6B1E-4BD1-9321-0844908DC1A5 Q34639285-C08F39DF-74C4-431C-9A4F-C1177F87EFE7 Q34662234-B2E2BF41-1FCC-4609-9FA4-AD33A450ED5D Q34755301-AB7DF30C-7D05-403E-8E55-F058B72D5CDD Q35056596-A66AA327-8710-4E93-AE5E-94D2938B1122 Q35828879-14DAD5D0-AC13-4981-B9F7-AD30CEE17F93 Q35861181-471BE57C-270F-4661-9B45-3990055CD3C6 Q35908952-BD4A9ED4-61E4-46A7-BEAF-0135089B9592 Q36114710-5C5279AA-3775-4579-86F0-47D08CCC6AE8 Q36236937-F4BD4024-9A38-4972-8044-47D87E71BE24 Q36257964-880FD7B1-524F-4D28-B23C-C89BF1198F9B Q36299887-A65E72E6-399B-4E04-98F1-BE279E4D1127 Q36487609-E084E3E5-E5BB-4401-B0CA-EB89746ED90E Q36808534-ABE5230B-8993-487D-86A8-B47D23291599 Q36811368-45850C2D-E002-42A8-932A-B40D27A08C2F Q37230041-E10CC3F7-E3D6-423E-A082-1E816628C762 Q37294759-1748FAB5-ED1A-4B86-B4C9-9B0C6B27CAAF Q37421772-EBD76F03-B77D-46C3-AD81-BE486BA2A80A Q37553920-398E5311-C333-4354-BB7E-472174162864 Q37627081-70119AC0-BB6A-4B02-9C59-5463EFCC2CEC Q37644606-1AFFECEB-65F4-401C-A830-2609C7357084 Q37819720-70074A65-3DEF-4186-8FC3-8E3CD53C2957 Q38087849-03DC63E8-6F1C-4F2A-BE61-F4AE06FF06A1 Q38115460-A582A7A4-0232-40C2-A53C-8C1382830963

P2860

Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

http://www.wikidata.org/entity/Q33234966

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@ast

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@en

type

label

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@ast

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@en

prefLabel

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@ast

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@en

P1433

Q33234966-E930931A-7C7A-4ECB-AF06-371C84D2F3A9

P1476

Q33234966-E3D5576B-31E9-461F-9408-0F22CDDEF98F

P2093

Q33234966-1B6B0639-49A7-4E5B-8632-C4212B93FC4D

Q33234966-29192260-C457-416B-8F26-97FF726D60B3

Q33234966-4DEB98DE-487B-4FD9-A195-9D2F2C380B8D

Q33234966-65DD8A6E-7503-4366-BA23-940783F0C798

Q33234966-6FD4FB40-0EA4-474B-8BCC-EB650E85F893

Q33234966-887F0FD5-D211-4CB1-903C-D44F8D119BBC

Q33234966-E32836F7-731A-4B5A-9F33-21BFD7AC580C

Q33234966-E734836C-729F-41ED-B522-A381EAC32004

P304

Q33234966-83C50782-B0D2-407E-96E1-7BFFCA3EA84A

P31

Q33234966-6930F6A6-4DFB-4316-87AC-113CC35C0BC3

P356

Q33234966-F582997A-1B18-4187-B47C-7BF777612E15

P407

Q33234966-164C7AF1-0D9A-4CEC-A2E4-B5D16E6B71E9

P433

Q33234966-69E70464-DB06-4B19-979D-C9867ABB35C4

P478

Q33234966-A0BB378A-3190-4DEB-81F9-ADE08BE8DB60

P577

Q33234966-FEA2EC54-B0F0-4BAB-B053-9F9808D66CFB

P698

Q33234966-680EA2B8-E727-4AD6-8061-CCAC34E4463A

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Complement component 1Q (C1Q) ...... , and human glaucomatous eyes.

@en

P2093

Dalia Nagel

http://www.w3.org/2001/XMLSchema#string

John Danias

http://www.w3.org/2001/XMLSchema#string

Kalliopi Stasi

http://www.w3.org/2001/XMLSchema#string

Lizhen Ren

http://www.w3.org/2001/XMLSchema#string

Rong-Fang Wang

http://www.w3.org/2001/XMLSchema#string

Steven M Podos

http://www.w3.org/2001/XMLSchema#string

Thom Mittag

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Yang

http://www.w3.org/2001/XMLSchema#string

P304

1024-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.05-0830

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16505037

http://www.w3.org/2001/XMLSchema#string